Literature DB >> 26082077

A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis.

Ryan B Perumpail1, Robert J Wong2, Edward A Pham1, John P Higgins3, Tami J Daugherty1, Aijaz Ahmed4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26082077     DOI： 10.1007/s10620-015-3756-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  3 in total

1.  Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis.

Authors:  R B Perumpail; R J Wong; L D Ha; E A Pham; U Wang; H Luong; R Kumari; T J Daugherty; J P Higgins; Z M Younossi; W R Kim; J S Glenn; A Ahmed
Journal:  Transpl Infect Dis       Date:  2015-01-31       Impact factor: 2.228

2.  Sofosbuvir for previously untreated chronic hepatitis C infection.

Authors:  Eric Lawitz; Alessandra Mangia; David Wyles; Maribel Rodriguez-Torres; Tarek Hassanein; Stuart C Gordon; Michael Schultz; Mitchell N Davis; Zeid Kayali; K Rajender Reddy; Ira M Jacobson; Kris V Kowdley; Lisa Nyberg; G Mani Subramanian; Robert H Hyland; Sarah Arterburn; Deyuan Jiang; John McNally; Diana Brainard; William T Symonds; John G McHutchison; Aasim M Sheikh; Zobair Younossi; Edward J Gane
Journal:  N Engl J Med       Date:  2013-04-23       Impact factor: 91.245

3.  Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study.

Authors:  Eric Lawitz; Mark S Sulkowski; Reem Ghalib; Maribel Rodriguez-Torres; Zobair M Younossi; Ana Corregidor; Edwin DeJesus; Brian Pearlman; Mordechai Rabinovitz; Norman Gitlin; Joseph K Lim; Paul J Pockros; John D Scott; Bart Fevery; Tom Lambrecht; Sivi Ouwerkerk-Mahadevan; Katleen Callewaert; William T Symonds; Gaston Picchio; Karen L Lindsay; Maria Beumont; Ira M Jacobson
Journal:  Lancet       Date:  2014-07-28       Impact factor: 79.321
  3 in total
  3 in total

1.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

Review 2.  Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment.

Authors:  Goki Suda; Koji Ogawa; Megumi Kimura; Masato Nakai; Takuya Sho; Kenichi Morikawa; Naoya Sakamoto
Journal:  J Clin Transl Hepatol       Date:  2016-12-26

3.  Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience.

Authors:  Avin Aggarwal; Eric R Yoo; Ryan B Perumpail; George Cholankeril; Radhika Kumari; Tami J Daugherty; Alex S Lapasaran; Aijaz Ahmed
Journal:  J Clin Transl Hepatol       Date:  2017-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.